UNE-EN ISO 20776-1:2021
Current
The latest, up-to-date edition.
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases (ISO 20776-1:2019, including Corrected version 2019-12)
Hardcopy , PDF
Spanish, Castilian, English
10-02-2021
This part of ISO 20776 describes one reference method, broth micro-dilution, for determination of MICs.
The MIC may be a guide for the clinician, and reflects the activity of the drug under the described test
conditions, by taking into account other factors, such as drug pharmacology, pharmacokinetics, or
bacterial resistance mechanisms. This allows categorisation of bacteria as susceptible (S),
intermediate (I), or resistant (R). In addition, MIC distributions can be used to define wild type or non119
wild type bacterial populations. Although clinical interpretation of the MIC value is beyond the scope of
this part of ISO 20776, modifications of the basic method are required for certain antimicrobial agent -
bacteria combinations to facilitate clinical interpretation. These modifications are included in a separate
Annex of this document. It is necessary to compare other susceptibility testing methods (e.g. disc diffusion
or diagnostic test devices) with this reference method for validation, in order to ensure comparable and
reliable results.
| Committee |
CTN 129
|
| DocumentType |
Standard
|
| Pages |
29
|
| PublisherName |
Asociación Española de Normalización
|
| Status |
Current
|
| Standards | Relationship |
| ISO 20776-1:2019 | Identical |
| EN ISO 20776-1:2020 | Identical |
Access your standards online with a subscription
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.